Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-09 Sale | 2023-08-10 06:50 am | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $18.27 | $965,402 | 17,836 (Direct) | View |
| 2023-07-10 Sale | 2023-07-11 09:23 am | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $20.4 | $1,078,068 | 17,836 (Direct) | View |
| 2023-06-09 Sale | 2023-06-09 5:32 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $21.18 | $1,119,421 | 17,836 (Direct) | View |
| 2023-05-09 Sale | 2023-05-10 4:11 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $21.41 | $1,131,478 | 17,836 (Direct) | View |
| 2023-04-10 Sale | 2023-04-12 4:03 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $19.53 | $1,032,237 | 17,836 (Direct) | View |
| 2023-03-13 Sale | 2023-03-14 4:42 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 52,854 | $22.53 | $1,190,674 | 17,836 (Direct) | View |
| 2023-02-06 Sale | 2023-02-08 4:49 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 52,854 | $26.83 | $1,417,909 | 17,836 (Direct) | View |
| 2022-09-19 Sale | 2022-09-21 4:18 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 173,988 | $23.11 | $4,020,056 | 17,836 (Direct) | View |
| 2022-09-14 Sale | 2022-09-16 5:34 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 279,420 | $23.64 | $6,604,327 | 17,836 (Direct) | View |
| 2022-07-01 Sale | 2022-07-05 4:09 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 62,292 | $19 | $1,183,430 | 17,836 (Direct) | View |
| 2022-04-14 Sale | 2022-04-18 9:00 pm | ARVINAS INC. | ARVN | Morrison Briggs Director | 20,960 | $66.44 | $1,392,616 | 20,470 (Direct) | View |
| 2022-04-01 Sale | 2022-04-05 4:05 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 104,173 | $17.48 | $1,820,735 | 17,836 (Direct) | View |
| 2022-01-14 Sale | 2022-01-19 9:00 pm | ARVINAS INC. | ARVN | Morrison Briggs Director | 20,960 | $65.55 | $1,374,021 | 41,430 (Direct) | View |
| 2021-12-17 Sale | 2021-12-20 6:44 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer | 35,156 | $20 | $703,120 | 48,336 (Direct) | View |
| 2021-09-17 Sale | 2021-09-21 4:35 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer | 70,312 | $20.07 | $1,411,018 | 48,336 (Direct) | View |
| 2021-02-17 Purchase | 2021-02-17 6:05 pm | Codiak BioSciences Inc. | CDAK | Morrison Briggs Director | 4,761 | $21 | $99,981 | 4,761 (Direct) | View |
| 2021-02-08 Sale | 2021-02-10 4:23 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer | 35,156 | $20.55 | $722,403 | 48,336 (Direct) | View |
| 2020-11-09 Sale | 2020-11-12 5:55 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer | 80,404 | $20.04 | $1,611,577 | 46,565 (Direct) | View |
| 2020-06-23 Purchase | 2020-06-25 5:57 pm | Repare Therapeutics Inc. | RPTX | Morrison Briggs Director | 4,800 | $20 | $96,000 | 4,800 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-07 Option Award | 2024-02-09 4:04 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 17,000 | $0 | 34,836 (Direct) | View |
| 2023-08-09 Exercise | 2023-08-10 06:50 am | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $8.77 | 17,836 (Direct) | View |
| 2023-08-09 Exercise | 2023-08-10 06:50 am | 2027-02-06 N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $0 | 17,836 (Direct) | View |
| 2023-07-10 Exercise | 2023-07-11 09:23 am | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $8.77 | 17,836 (Direct) | View |
| 2023-07-10 Exercise | 2023-07-11 09:23 am | N/A 2027-02-06 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $0 | 17,836 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 5:07 pm | N/A 2033-06-20 | Werewolf Therapeutics Inc. | HOWL | Morrison Briggs Director | 13,200 | $0 | 13,200 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:27 pm | N/A 2033-06-14 | ARVINAS INC. | ARVN | Morrison Briggs Director | 16,908 | $0 | 36,884 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:27 pm | N/A 2033-06-07 | Repare Therapeutics Inc. | RPTX | Morrison Briggs Director | 27,200 | $0 | 27,200 (Direct) | View |
| 2023-06-09 Exercise | 2023-06-09 5:32 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 24,582 | $6.38 | 17,836 (Direct) | View |
| 2023-06-09 Exercise | 2023-06-09 5:32 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 28,273 | $8.77 | 17,836 (Direct) | View |
| 2023-06-09 Exercise | 2023-06-09 5:32 pm | N/A 2027-02-06 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $0 | 17,836 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 6:11 pm | N/A 2033-06-06 | Carisma Therapeutics Inc. | CARM | Morrison Briggs Director | 38,700 | $0 | 38,700 (Direct) | View |
| 2023-05-09 Exercise | 2023-05-10 4:11 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $6.38 | 17,836 (Direct) | View |
| 2023-05-09 Exercise | 2023-05-10 4:11 pm | N/A 2029-02-06 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $0 | 17,836 (Direct) | View |
| 2023-04-10 Exercise | 2023-04-12 4:03 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $6.38 | 17,836 (Direct) | View |
| 2023-04-10 Exercise | 2023-04-12 4:03 pm | N/A 2029-02-06 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $0 | 17,836 (Direct) | View |
| 2023-03-13 Exercise | 2023-03-14 4:42 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 52,854 | $6.38 | 17,836 (Direct) | View |
| 2023-03-13 Exercise | 2023-03-14 4:42 pm | N/A 2029-02-06 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 52,854 | $0 | 17,836 (Direct) | View |
| 2023-03-07 Option Award | 2023-03-09 9:21 pm | N/A 2030-07-23 | Carisma Therapeutics Inc. | CARM | Morrison Briggs Director | 109,674 | $0 | 109,674 (Direct) | View |
| 2023-02-06 Exercise | 2023-02-08 4:49 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 52,854 | $6.38 | 17,836 (Direct) | View |
| 2023-02-06 Exercise | 2023-02-08 4:49 pm | N/A 2029-02-06 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 52,854 | $0 | 17,836 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-03 5:02 pm | N/A 2033-02-02 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 32,000 | $28.55 | 32,000 (Direct) | View |
| 2022-09-19 Exercise | 2022-09-21 4:18 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 173,988 | $10.9 | 17,836 (Direct) | View |
| 2022-09-19 Exercise | 2022-09-21 4:18 pm | N/A 2025-09-09 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 173,988 | $0 | 17,836 (Direct) | View |
| 2022-09-16 Exercise | 2022-09-16 5:34 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 53,034 | $10.9 | 17,836 (Direct) | View |
| 2022-09-14 Exercise | 2022-09-16 5:34 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 226,386 | $7.2 | 17,836 (Direct) | View |
| 2022-09-14 Exercise | 2022-09-16 5:34 pm | N/A 2025-06-30 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 279,420 | $0 | 17,836 (Direct) | View |
| 2022-07-01 Exercise | 2022-07-05 4:09 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 62,292 | $7.2 | 17,836 (Direct) | View |
| 2022-07-01 Exercise | 2022-07-05 4:09 pm | N/A 2025-06-30 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 62,292 | $0 | 17,836 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 8:00 pm | N/A 2032-06-15 | ARVINAS INC. | ARVN | Morrison Briggs Director | 10,192 | $0 | 10,192 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:41 pm | N/A 2032-05-31 | Werewolf Therapeutics Inc. | HOWL | Morrison Briggs Director | 11,600 | $0 | 11,600 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-16 7:25 pm | N/A 2032-05-13 | Repare Therapeutics Inc. | RPTX | Morrison Briggs Director | 49,000 | $0 | 49,000 (Direct) | View |
| 2022-04-14 Exercise | 2022-04-18 9:00 pm | N/A N/A | ARVINAS INC. | ARVN | Morrison Briggs Director | 16,188 | $16 | 20,470 (Direct) | View |
| 2022-04-14 Exercise | 2022-04-18 9:00 pm | N/A 2028-09-25 | ARVINAS INC. | ARVN | Morrison Briggs Director | 16,188 | $0 | 20,470 (Direct) | View |
| 2022-04-01 Exercise(A) | 2022-04-13 4:09 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 73,673 | $7.2 | 20,964 (Direct) | View |
| 2022-04-01 Exercise(A) | 2022-04-13 4:09 pm | N/A 2025-06-30 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 73,673 | $0 | 20,964 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-05 4:05 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 73,673 | $10.9 | 17,836 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-05 4:05 pm | N/A 2025-09-09 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 73,673 | $0 | 17,836 (Direct) | View |
| 2022-02-02 Option Award | 2022-02-03 5:32 pm | N/A 2032-02-02 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 160,000 | $15.79 | 160,000 (Direct) | View |
| 2022-01-14 Exercise | 2022-01-19 9:00 pm | N/A N/A | ARVINAS INC. | ARVN | Morrison Briggs Director | 16,188 | $16 | 41,430 (Direct) | View |
| 2022-01-14 Exercise | 2022-01-19 9:00 pm | N/A 2028-09-25 | ARVINAS INC. | ARVN | Morrison Briggs Director | 16,188 | $0 | 41,430 (Direct) | View |
| 2021-12-17 Exercise | 2021-12-20 6:44 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer | 35,156 | $10.9 | 48,336 (Direct) | View |
| 2021-12-17 Exercise | 2021-12-20 6:44 pm | N/A 2025-09-09 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer | 35,156 | $0 | 48,336 (Direct) | View |
| 2021-09-17 Exercise | 2021-09-21 4:35 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer | 70,312 | $7.2 | 48,336 (Direct) | View |
| 2021-09-17 Exercise | 2021-09-21 4:35 pm | N/A 2025-06-30 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer | 70,312 | $0 | 48,336 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 8:00 pm | N/A 2021-06-07 | ARVINAS INC. | ARVN | Morrison Briggs Director | 7,511 | $0 | 7,511 (Direct) | View |
| 2021-05-13 Option Award | 2021-05-14 4:53 pm | N/A 2031-05-13 | Repare Therapeutics Inc. | RPTX | Morrison Briggs Director | 21,000 | $0 | 21,000 (Direct) | View |
| 2021-04-30 Option Award | 2021-05-04 4:30 pm | N/A 2031-04-29 | Werewolf Therapeutics Inc. | HOWL | Morrison Briggs Director | 23,200 | $0 | 23,200 (Direct) | View |
Ownership | 2021-04-29 4:58 pm | N/A N/A | Werewolf Therapeutics Inc. | HOWL | Morrison Briggs Director | 0 | $0 | 46,570 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 4:23 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer | 35,156 | $7.2 | 48,336 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 4:23 pm | N/A 2025-06-30 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer | 35,156 | $0 | 48,336 (Direct) | View |
| 2021-01-31 Other | 2021-02-05 4:21 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer | 1,771 | $12 | 245,107 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 4:21 pm | N/A 2031-02-03 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer | 195,000 | $0 | 245,107 (Direct) | View |
| 2020-11-09 Exercise | 2020-11-12 5:55 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer | 80,404 | $7.2 | 46,565 (Direct) | View |
| 2020-11-09 Exercise | 2020-11-12 5:55 pm | N/A 2025-06-01 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer | 80,404 | $0 | 46,565 (Direct) | View |
| 2020-10-13 Option Award | 2020-10-15 8:10 pm | N/A 2030-10-12 | Codiak BioSciences Inc. | CDAK | Morrison Briggs Director | 10,000 | $0 | 10,000 (Direct) | View |
Ownership | 2020-10-13 9:21 pm | N/A 2028-03-28 | Codiak BioSciences Inc. | CDAK | Morrison Briggs Director | 0 | $0 | 28,783 (Direct) | View |
Ownership | 2020-10-01 7:13 pm | N/A 2026-04-26 | Oncorus Inc. | ONCR | Morrison Briggs Director | 0 | $0 | 32,846 (Direct) | View |